다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
초록이 없습니다.
1 American Diabetes Association: Medical Management of Type 1 Diabetes. 5th ed. Alexandria, VA, American Diabetes Association, 2008
2 American Diabetes Association: Medical Management of Type 2 Diabetes. 6th ed. Alexandria, VA, American Diabetes Association, 2008
3 American Diabetes Association: Intensive Diabetes Management. Alexandria, VA, American Diabetes Association, 2003
4 Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20 : 1183 ？1197, 1997 9203460
5 Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26 : 3160 ？3167, 2003 14578255
6 Davidson MB, Schriger DL, Peters AL, Lorber B: Relationship between fasting plasma glucose and glycosylated hemoglobin: potential for false-positive diagnoses of type 2 diabetes using new diagnostic criteria. JAMA 281 : 1203 ？1210, 1999 10199430
7 Nathan DM, Davidson MB, DeFronzo RA, Heine RJ, Henry RR, Pratley R, Zinman B: Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care 30 : 753 ？759, 2007 17327355
8 Engelgau MM, Narayan KM, Herman WH: Screening for type 2 diabetes. Diabetes Care 23 : 1563 ？1580, 2000 11023153
9 Gabir MM, Hanson RL, Dabelea D, Imperatore G, Roumain J, Bennett PH, Knowler WC: The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes. Diabetes Care 23 : 1108 ？1112, 2000 10937506
10 Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346 : 393 ？403, 2002 11832527
11 Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344 : 1343 ？1350, 2001 11333990
12 Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, Hu ZX, Lin J, Xiao JZ, Cao HB, Liu PA, Jiang XG, Jiang YY, Wang JP, Zheng H, Zhang H, Bennett PH, Howard BV: Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and Diabetes Study. Diabetes Care 20 : 537 ？544, 1997 9096977
13 Buchanan TA, Xiang AH, Peters RK, Kjos SL, Marroquin A, Goico J, Ochoa C, Tan S, Berkowitz K, Hodis HN, Azen SP: Preservation of pancreatic β-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women. Diabetes 51 : 2796 ？2803, 2002 12196473
14 Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M: Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 359 : 2072 ？2077, 2002 12086760
15 Gerstein HC, Yusuf S, Bosch J, Pogue J, Sheridan P, Dinccag N, Hanefeld M, Hoogwerf B, Laakso M, Mohan V, Shaw J, Zinman B, Holman RR: Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet 368 : 1096 ？1105, 2006 16997664
16 Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD, Vijay V: The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia 49 : 289 ？297, 2006 16391903
17 Johnson SL, Tabaei BP, Herman WH: The efficacy and cost of alternative strategies for systematic screening for type 2 diabetes in the U.S. population 45？74 years of age. Diabetes Care 28 : 307 ？311, 2005 15677784
18 Harris R, Donahue K, Rathore SS, Frame P, Woolf SH, Lohr KN: Screening adults for type 2 diabetes: a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 138 : 215 ？229, 2003 12558362
19 USPSTF: Screening for type 2 diabetes mellitus in adults: recommendations and rationale. Ann Intern Med 138 : 212 ？214, 2003 12558361
20 Dabelea D, Bell RA, D'Agostino RB Jr, Imperatore G, Johansen JM, Linder B, Liu LL, Loots B, Marcovina S, Mayer-Davis EJ, Pettitt DJ, Waitzfelder B: Incidence of diabetes in youth in the United States. JAMA 297 : 2716 ？2724, 2007 17595272
21 Liese AD, D'Agostino RB Jr, Hamman RF, Kilgo PD, Lawrence JM, Liu LL, Loots B, Linder B, Marcovina S, Rodriguez B, Standiford D, Williams DE: The burden of diabetes mellitus among US youth: prevalence estimates from the SEARCH for Diabetes in Youth Study. Pediatrics 118 : 1510 ？1518, 2006 17015542
22 American Diabetes Association: Type 2 diabetes in children and adolescents (Consensus Statement). Diabetes Care 23 : 381 ？389, 2000 10868870
23 American Diabetes Association: Gestational diabetes mellitus (Position Statement). Diabetes Care 27 (Suppl. 1): S88 ？S90, 2004 14693936
24 Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, Hadden DR, McCance DR, Hod M, McIntyre HD, Oats JJ, Persson B, Rogers MS, Sacks DA: Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 358 : 1991 ？2002, 2008 18463375
25 Kim C, Newton KM, Knopp RH: Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 25 : 1862 ？1868, 2002 12351492
26 Lindstrom J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson JG, Hemio K, Hamalainen H, Harkonen P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Mannelin M, Paturi M, Sundvall J, Valle TT, Uusitupa M, Tuomilehto J: Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet 368 : 1673 ？1679, 2006 17098085
27 Li G, Zhang P, Wang J, Gregg EW, Yang W, Gong Q, Li H, Li H, Jiang Y, An Y, Shuai Y, Zhang B, Zhang J, Thompson TJ, Gerzoff RB, Roglic G, Hu Y, Bennett PH: The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet 371 : 1783 ？1789, 2008 18502303
28 Kosaka K, Noda M, Kuzuya T: Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males. Diabetes Res Clin Pract 67 : 152 ？162, 2005 15649575
29 Torgerson JS, Hauptman J, Boldrin MN, Sjostrom L: XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care 27 : 155 ？161, 2004 14693982
30 Gerstein HC: Point: If it is important to prevent type 2 diabetes, it is important to consider all proven therapies within a comprehensive approach. Diabetes Care 30 : 432 ？434, 2007 17259525
31 American Diabetes Association: Consensus statement on self-monitoring of blood glucose. Diabetes Care 10 : 95 ？99, 1987 3552518
32 American Diabetes Asociation: Self-monitoring of blood glucose. Diabetes Care 17 : 81 ？86, 1994 8112195
33 Welschen LM, Bloemendal E, Nijpels G, Dekker JM, Heine RJ, Stalman WA, Bouter LM: Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: a systematic review. Diabetes Care 28 : 1510 ？1517, 2005 15920083
34 Farmer A, Wade A, Goyder E, Yudkin P, French D, Craven A, Holman R, Kinmonth AL, Neil A: Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial. BMJ 335 : 132 , 2007 17591623
35 O'Kane MJ, Bunting B, Copeland M, Coates VE: Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial. BMJ 336 : 1174 ？1177, 2008 18420662
36 Simon J, Gray A, Clarke P, Wade A, Neil A, Farmer A: Cost effectiveness of self monitoring of blood glucose in patients with non-insulin treated type 2 diabetes: economic evaluation of data from the DiGEM trial. BMJ 336 : 1177 ？1180, 2008 18420663
37 Sacks DB, Bruns DE, Goldstein DE, Maclaren NK, McDonald JM, Parrott M: Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 48 : 436 ？472, 2002 11861436
38 The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group: Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med 359 : 1464 ？1476, 2008 18779236
39 Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR: Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321 : 405 ？412, 2000 10938048
40 Cagliero E, Levina EV, Nathan DM: Immediate feedback of HbA1c levels improves glycemic control in type 1 and insulin-treated type 2 diabetic patients. Diabetes Care 22 : 1785 ？1789, 1999 10546008
41 Miller CD, Barnes CS, Phillips LS, Ziemer DC, Gallina DL, Cook CB, Maryman SD, El Kebbi IM: Rapid A1c availability improves clinical decision-making in an urban primary care clinic. Diabetes Care 26 : 1158 ？1163, 2003 12663590
42 Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ: Translating the A1C assay into estimated average glucose values. Diabetes Care 31 : 1473 ？1478, 2008 18540046
43 Rohlfing CL, Wiedmeyer HM, Little RR, England JD, Tennill A, Goldstein DE: Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial. Diabetes Care 25 : 275 ？278, 2002 11815495
44 Wilson DM, Kollman: Relationship of A1C to glucose concentrations in children with type 1 diabetes: assessments by high-frequency glucose determinations by sensors. Diabetes Care 31 : 381 ？385, 2008 18056888
45 The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 329 : 977 ？986, 1993 8366922
46 Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. N Engl J Med 342 : 381 ？389, 2000 10666428
47 Martin CL, Albers J, Herman WH, Cleary P, Waberski B, Greene DA, Stevens MJ, Feldman EL: Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion. Diabetes Care 29 : 340 ？344, 2006 16443884
48 Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, Kojima Y, Furuyoshi N, Shichiri M: Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 28 : 103 ？117, 1995 7587918
49 Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34): UK Prospective Diabetes Study (UKPDS) Group. Lancet 352 : 854 ？865, 1998 9742977
50 Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33): UK Prospective Diabetes Study (UKPDS) Group. Lancet 352 : 837 ？853, 1998 9742976
51 Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA: 10-Year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 359 : 1577 ？1589, 2008 18784090
52 Lawson ML, Gerstein HC, Tsui E, Zinman B: Effect of intensive therapy on early macrovascular disease in young individuals with type 1 diabetes: a systematic review and meta-analysis. Diabetes Care 22 (Suppl. 2): B35 ？B39, 1999 10097897
53 Selvin E, Marinopoulos S, Berkenblit G, Rami T, Brancati FL, Powe NR, Golden SH: Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 141 : 421 ？431, 2004 15381515
54 Stettler C, Allemann S, Juni P, Cull CA, Holman RR, Egger M, Krahenbuhl S, Diem P: Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: meta-analysis of randomized trials. Am Heart J 152 : 27 ？38, 2006 16824829
55 Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, Raskin P, Zinman B: Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353 : 2643 ？2653, 2005 16371630
56 Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, Grimm RH Jr, Probstfield JL, Simons-Morton DG, Friedewald WT: Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358 : 2545 ？2559, 2008 18539917
57 Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, Marre M, Cooper M, Glasziou P, Grobbee D, Hamet P, Harrap S, Heller S, Liu L, Mancia G, Mogensen CE, Pan C, Poulter N, Rodgers A, Williams B, Bompoint S, De Galan BE, Joshi R, Travert F: Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 358 : 2560 ？2572, 2008 18539916
58 Duckworth W: VADT results. Presented at the 68th Annual Meeting of the American Diabetes Association, 6？10 June 2008 , at the Moscone Convention Center, San Francisco, CA
59 American Diabetes Association: Postprandial blood glucose (Consensus Statement). Diabetes Care 24 : 775 ？778, 2001 11315848
60 Ceriello A, Taboga C, Tonutti L, Quagliaro L, Piconi L, Bais B, Da Ros R, Motz E: Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: effects of short- and long-term simvastatin treatment. Circulation 106 : 1211 ？1218, 2002 12208795
61 Metzger BE, Buchanan TA, Coustan DR, de Leiva A, Dunger DB, Hadden DR, Hod M, Kitzmiller JL, Kjos SL, Oats JN, Pettitt DJ, Sacks DA, Zoupas C: Summary and recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care 30 (Suppl. 2): S251 ？S260, 2007 17596481
62 Kitzmiller JL, Block JM, Brown FM, Catalano PM, Conway DL, Coustan DR, Gunderson EP, Herman WH, Hoffman LD, Inturrisi M, Jovanovic LB, Kjos SI, Knopp RH, Montoro MN, Ogata ES, Paramsothy P, Reader DM, Rosenn BM, Thomas AM, Kirkman MS: Managing preexisting diabetes for pregnancy: summary of evidence and consensus recommendations for care. Diabetes Care 31 : 1060 ？1079, 2008 18445730
63 DeWitt DE, Hirsch IB: Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review. JAMA 289 : 2254 ？2264, 2003 12734137
64 Rosenstock J, Dailey G, Massi-Benedetti M, Fritsche A, Lin Z, Salzman A: Reduced hypoglycemia risk with insulin glargine: a meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes. Diabetes Care 28 : 950 ？955, 2005 15793205
65 Mooradian AD, Bernbaum M, Albert SG: Narrative review: a rational approach to starting insulin therapy. Ann Intern Med 145 : 125 ？134, 2006 16847295
66 Nathan DM, Buse JB, Davidson MB, Heine RJ, Holman RR, Sherwin R, Zinman B: Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 29 : 1963 ？1972, 2006 16873813
67 Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, and Zinman B: Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 32 : 193 ？203, 2009 18945920
68 American Diabetes Association: Nutrition recommendations and interventions for diabetes―2006. Diabetes Care 29 : 2140 ？2157, 2006 16936169
69 DAFNE Study Group: Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial. BMJ 325 : 746 , 2002 12364302
70 Franz MJ, Monk A, Barry B, McClain K, Weaver T, Cooper N, Upham P, Bergenstal R, Mazze RS: Effectiveness of medical nutrition therapy provided by dietitians in the management of non-insulin-dependent diabetes mellitus: a randomized, controlled clinical trial. J Am Diet Assoc 95 : 1009 ？1017, 1995 7657902
71 Goldhaber-Fiebert JD, Goldhaber-Fiebert SN, Tristan ML, Nathan DM: Randomized controlled community-based nutrition and exercise intervention improves glycemia and cardiovascular risk factors in type 2 diabetic patients in rural Costa Rica. Diabetes Care 26 : 24 ？29, 2003 12502654
72 Lemon CC, Lacey K, Lohse B, Hubacher DO, Klawitter B, Palta M: Outcomes monitoring of health, behavior, and quality of life after nutrition intervention in adults with type 2 diabetes. J Am Diet Assoc 104 : 1805 ？1815, 2004 15565074
73 Miller CK, Edwards L, Kissling G, Sanville L: Nutrition education improves metabolic outcomes among older adults with diabetes mellitus: results from a randomized controlled trial. Prev Med 34 : 252 ？259, 2002 11817922
74 Wilson C, Brown T, Acton K, Gilliland S: Effects of clinical nutrition education and educator discipline on glycemic control outcomes in the Indian health service. Diabetes Care 26 : 2500 ？2504, 2003 12941709
75 Graber AL, Elasy TA, Quinn D, Wolff K, Brown A: Improving glycemic control in adults with diabetes mellitus: shared responsibility in primary care practices. South Med J 95 : 684 ？690, 2002 12144072
76 Gaetke LM, Stuart MA, Truszczynska H: A single nutrition counseling session with a registered dietitian improves short-term clinical outcomes for rural Kentucky patients with chronic diseases. J Am Diet Assoc 106 : 109 ？112, 2006 16390674
77 Yu-Poth S, Zhao G, Etherton T, Naglak M, Jonnalagadda S, Kris-Etherton PM: Effects of the National Cholesterol Education Program's Step I and Step II dietary intervention programs on cardiovascular disease risk factors: a meta-analysis. Am J Clin Nutr 69 : 632 ？646, 1999 10197564
78 Van Horn L, McCoin M, Kris-Etherton PM, Burke F, Carson JA, Champagne CM, Karmally W, Sikand G: The evidence for dietary prevention and treatment of cardiovascular disease. J Am Diet Assoc 108 : 287 ？331, 2008 18237578
79 Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, Bray GA, Vogt TM, Cutler JA, Windhauser MM, Lin PH, Karanja N: A clinical trial of the effects of dietary patterns on blood pressure: DASH Collaborative Research Group. N Engl J Med 336 : 1117 ？1124, 1997 9099655
80 Norris SL, Zhang X, Avenell A, Gregg E, Bowman B, Schmid CH, Lau J: Long-term effectiveness of weight-loss interventions in adults with pre-diabetes: a review. Am J Prev Med 28 : 126 ？139, 2005
81 Klein S, Sheard NF, Pi-Sunyer X, Daly A, Wylie-Rosett J, Kulkarni K, Clark NG: Weight management through lifestyle modification for the prevention and management of type 2 diabetes: rationale and strategies: a statement of the American Diabetes Association, the North American Association for the Study of Obesity, and the American Society for Clinical Nutrition. Diabetes Care 27 : 2067 ？2073, 2004 15277443
82 Norris SL, Zhang X, Avenell A, Gregg E, Schmid CH, Kim C, Lau J: Efficacy of pharmacotherapy for weight loss in adults with type 2 diabetes mellitus: a meta-analysis. Arch Intern Med 164 : 1395 ？1404, 2004 15249348
83 Wolf AM, Conaway MR, Crowther JQ, Hazen KY, Nadler L, Oneida B, Bovbjerg VE: Translating lifestyle intervention to practice in obese patients with type 2 diabetes: Improving Control with Activity and Nutrition (ICAN) study. Diabetes Care 27 : 1570 ？1576, 2004 15220230
84 Manning RM, Jung RT, Leese GP, Newton RW: The comparison of four weight reduction strategies aimed at overweight patients with diabetes mellitus: four-year follow-up. Diabet Med 15 : 497 ？502, 1998 9632125
85 Shai I, Schwarzfuchs D, Henkin Y, Shahar DR, Witkow S, Greenberg I, Golan R, Fraser D, Bolotin A, Vardi H, Tangi-Rozental O, Zuk-Ramot R, Sarusi B, Brickner D, Schwartz Z, Sheiner E, Marko R, Katorza E, Thiery J, Fiedler GM, Bluher M, Stumvoll M, Stampfer MJ: Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N Engl J Med 359 : 229 ？241, 2008 18635428
86 Franz MJ, VanWormer JJ, Crain AL, Boucher JL, Histon T, Caplan W, Bowman JD, Pronk NP: Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up. J Am Diet Assoc 107 : 1755 ？1767, 2007 17904936
87 Pi-Sunyer X, Blackburn G, Brancati FL, Bray GA, Bright R, Clark JM, Curtis JM, Espeland MA, Foreyt JP, Graves K, Haffner SM, Harrison B, Hill JO, Horton ES, Jakicic J, Jeffery RW, Johnson KC, Kahn S, Kelley DE, Kitabchi AE, Knowler WC, Lewis CE, Maschak-Carey BJ, Montgomery B, Nathan DM, Patricio J, Peters A, Redmon JB, Reeves RS, Ryan DH, Safford M, Van Dorsten B, Wadden TA, Wagenknecht L, Wesche-Thobaben J, Wing RR, Yanovski SZ: Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: 1-year results of the Look AHEAD trial. Diabetes Care 30 : 1374 ？1383, 2007 17363746
88 Foster GD, Wyatt HR, Hill JO, McGuckin BG, Brill C, Mohammed BS, Szapary PO, Rader DJ, Edman JS, Klein S: A randomized trial of a low-carbohydrate diet for obesity. N Engl J Med 348 : 2082 ？2090, 2003 12761365
89 Stern L, Iqbal N, Seshadri P, Chicano KL, Daily DA, McGrory J, Williams M, Gracely EJ, Samaha FF: The effects of low-carbohydrate versus conventional weight loss diets in severely obese adults: one-year follow-up of a randomized trial. Ann Intern Med 140 : 778 ？785, 2004 15148064
90 Gardner C, Kiazand A, Alhassan S, Soowon K, Stafford R, Balise R, Kraemer H, King A: Comparison of the Atkins, Zone, Ornish, and LEARN diets for change in weight and related risk factors among overweight premenopausal women JAMA 297 : 969 ？977, 2007 17341711
91 Nordmann AJ, Nordmann A, Briel M, Keller U, Yancy WS Jr, Brehm BJ, Bucher HC: Effects of low-carbohydrate vs low-fat diets on weight loss and cardiovascular risk factors: a meta-analysis of randomized controlled trials. Arch Intern Med 166 : 285 ？293, 2006 16476868
92 Institute of Medicine: Dietary Reference Intakes: Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids. Washington, D.C., National Academies Press, 2002
93 Barnard ND, Cohen J, Jenkins DJ, Turner-McGrievy G, Gloede L, Jaster B, Seidl K, Green AA, Talpers S: A low-fat vegan diet improves glycemic control and cardiovascular risk factors in a randomized clinical trial in individuals with type 2 diabetes. Diabetes Care 29 : 1777 ？1783, 2006 16873779
94 Turner-McGrievy GM, Barnard ND, Cohen J, Jenkins DJ, Gloede L, Green AA: Changes in nutrient intake and dietary quality among participants with type 2 diabetes following a low-fat vegan diet or a conventional diabetes diet for 22 weeks. J Am Diet Assoc 108 : 1636 ？1645, 2008 18926128
95 Franz MJ, Bantle JP, Beebe CA, Brunzell JD, Chiasson JL, Garg A, Holzmeister LA, Hoogwerf B, Mayer-Davis E, Mooradian AD, Purnell JQ, Wheeler M: Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. Diabetes Care 25 : 148 ？198, 2002 11772915
96 Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, Bantle JP, Sledge I: Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. In Press
97 Dixon JB, O'Brien PE, Playfair J, Chapman L, Schachter LM, Skinner S, Proietto J, Bailey M, Anderson M: Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA 299 : 316 ？323, 2008 18212316
98 Buchwald H, Estok R, Fahrbach K, Banel D, Sledge I: Trends in mortality in bariatric surgery: a systematic review and meta-analysis. Surgery 142 : 621 ？632, 2007 17950357
99 Sjostrom L, Narbro K, Sjostrom CD, Karason K, Larsson B, Wedel H, Lystig T, Sullivan M, Bouchard C, Carlsson B, Bengtsson C, Dahlgren S, Gummesson A, Jacobson P, Karlsson J, Lindroos AK, Lonroth H, Naslund I, Olbers T, Stenlof K, Torgerson J, Agren G, Carlsson LM: Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 357 : 741 ？752, 2007 17715408
100 Piette JD, Glasgow RE: Sttategies for improving behavioral and health outcomes among people with diabetes: self managemnt education. In Evidence-Based Diabetes Care. Gerstein HC, Hayes RB, Eds. Ontario, Canada, BC Decker, 2000
101 Norris SL, Engelgau MM, Narayan KM: Effectiveness of self-management training in type 2 diabetes: a systematic review of randomized controlled trials. Diabetes Care 24 : 561 ？587, 2001 11289485
102 Norris SL, Lau J, Smith SJ, Schmid CH, Engelgau MM: Self-management education for adults with type 2 diabetes: a meta-analysis of the effect on glycemic control. Diabetes Care 25 : 1159 ？1171, 2002 12087014
103 Gary TL, Genkinger JM, Guallar E, Peyrot M, Brancati FL: Meta-analysis of randomized educational and behavioral interventions in type 2 diabetes. Diabetes Educ 29 : 488 ？501, 2003 12854339
104 Steed L, Cooke D, Newman S: A systematic review of psychosocial outcomes following education, self-management and psychological interventions in diabetes mellitus. Patient Educ Couns 51 : 5 ？15, 2003 12915275
105 Ellis SE, Speroff T, Dittus RS, Brown A, Pichert JW, Elasy TA: Diabetes patient education: a meta-analysis and meta-regression. Patient Educ Couns 52 : 97 ？105, 2004 14729296
106 Warsi A, Wang PS, LaValley MP, Avorn J, Solomon DH: Self-management education programs in chronic disease: a systematic review and methodological critique of the literature. Arch Intern Med 164 : 1641 ？1649, 2004 15302634
107 Funnell MM, Brown TL, Childs BP, Haas LB, Hosey GM, Jensen B, Maryniuk M, Peyrot M, Piette JD, Reader D, Siminerio LM, Weinger K, Weiss MA: National standards for diabetes self-management education. Diabetes Care 30 : 1630 ？1637, 2007 17526822
108 Mulcahy K, Maryniuk M, Peeples M, Peyrot M, Tomky D, Weaver T, Yarborough P: Diabetes self-management education core outcomes measures. Diabetes Educ 29 : 768 -84:787, 2003 14603868
109 Glasgow RE, Peeples M, Skovlund SE: Where is the patient in diabetes performance measures? The case for including patient-centered and self-management measures. Diabetes Care 31 : 1046 ？1050, 2008 18445728
110 Barker JM, Goehrig SH, Barriga K, Hoffman M, Slover R, Eisenbarth GS, Norris JM, Klingensmith GJ, Rewers M: Clinical characteristics of children diagnosed with type 1 diabetes through intensive screening and follow-up. Diabetes Care 27 : 1399 ？1404, 2004 15161795
111 Rickheim PL, Weaver TW, Flader JL, Kendall DM: Assessment of group versus individual diabetes education: a randomized study. Diabetes Care 25 : 269 ？274, 2002 11815494
112 Trento M, Passera P, Borgo E, Tomalino M, Bajardi M, Cavallo F, Porta M: A 5-year randomized controlled study of learning, problem solving ability, and quality of life modifications in people with type 2 diabetes managed by group care. Diabetes Care 27 : 670 ？675, 2004 14988283
113 Norris SL, Chowdhury FM, Van Le K, Horsley T, Brownstein JN, Zhang X, Jack L Jr, Satterfield DW: Effectiveness of community health workers in the care of persons with diabetes. Diabet Med 23 : 544 ？556, 2006 16681564
114 Sigal RJ, Kenny GP, Wasserman DH, Castaneda-Sceppa C: Physical activity/exercise and type 2 diabetes. Diabetes Care 27 : 2518 ？2539, 2004 15451933
115 Wasserman DH, Zinman B: Exercise in individuals with IDDM. Diabetes Care 17 : 924 ？937, 1994 7956645
116 Boule NG, Haddad E, Kenny GP, Wells GA, Sigal RJ: Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials. JAMA 286 : 1218 ？1227, 2001 11559268
117 Boule NG, Kenny GP, Haddad E, Wells GA, Sigal RJ: Meta-analysis of the effect of structured exercise training on cardiorespiratory fitness in type 2 diabetes mellitus. Diabetologia 46 : 1071 ？1081, 2003 12856082
118 US Department of Health and Human Services: Physical Activity and Health: A Report of the Surgeon General. Atlanta, GA, Centers for Disease Control and Prevention, 1996
119 Ivy JL: Role of exercise training in the prevention and treatment of insulin resistance and non-insulin-dependent diabetes mellitus. Sports Med 24 : 321 ？336, 1997 9368278
120 Dunstan DW, Daly RM, Owen N, Jolley D, de Court, Shaw J, Zimmet P: High-intensity resistance training improves glycemic control in older patients with type 2 diabetes. Diabetes Care 25 : 1729 ？1736, 2002 12351469
121 Castaneda C, Layne JE, Munoz-Orians L, Gordon PL, Walsmith J, Foldvari M, Roubenoff R, Tucker KL, Nelson ME: A randomized controlled trial of resistance exercise training to improve glycemic control in older adults with type 2 diabetes. Diabetes Care 25 : 2335 ？2341, 2002 12453982
122 Sigal RJ, Kenny GP, Boule NG, Wells GA, Prud'homme D, Fortier M, Reid RD, Tulloch H, Coyle D, Phillips P, Jennings A, Jaffey J: Effects of aerobic training, resistance training, or both on glycemic control in type 2 diabetes: a randomized trial. Ann Intern Med 147 : 357 ？369, 2007 17876019
123 Bax JJ, Young LH, Frye RL, Bonow RO, Steinberg HO, Barrett EJ: Screening for coronary artery disease in patients with diabetes. Diabetes Care 30 : 2729 ？2736, 2007 17901530
124 Berger M, Berchtold P, Cuppers HJ, Drost H, Kley HK, Muller WA, Wiegelmann W, Zimmerman-Telschow H, Gries FA, Kruskemper HL, Zimmermann H: Metabolic and hormonal effects of muscular exercise in juvenile type diabetics. Diabetologia 13 : 355 ？365, 1977 410693
125 American Diabetes Association: Physical activity/exercise and diabetes (Position Statement). Diabetes Care 27 (Suppl. 1): S58 ？S62, 2004 14693927
126 Berger M: Adjustment of insulin and oral agent therapy. In Handbook of Exercise in Diabetes. 2nd ed. Ruderman N, Devlin JTSSH, Krisska A, Eds. Alexandria, VA, American Diabetes Association, 2002 , p. 365 ？376
127 Aiello LP, Wong J, Cavallerano J, Bursell SE, Aiello LM: Retinopathy. In Handbook of Exercise in Diabetes. 2nd ed. Ruderman N, Devlin JT, Kriska A, Eds. Alexandria, VA, American Diabetes Association, 2002 , p. 401 ？413
128 Vinik A, Erbas T: Neuropathy. In Handbook of Exercise in Diabetes. 2nd ed. Ruderman N, Devlin JT, Kriska A, Eds. Alexnadria, VA, Anerican Diabetes Association, 2002 , p. 463 ？496
129 Levin ME: The Diabetic Foot. In Handbook of Exercise in Diabetes. Ruderman N, Devlin JT, Kriska A, Eds. Alexandria, VA, American Diabetes Association, 2002, p. 385？399
130 Wackers FJ, Young LH, Inzucchi SE, Chyun DA, Davey JA, Barrett EJ, Taillefer R, Wittlin SD, Heller GV, Filipchuk N, Engel S, Ratner RE, Iskandrian AE: Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care 27 : 1954 ？1961, 2004 15277423
131 Valensi P, Sachs RN, Harfouche B, Lormeau B, Paries J, Cosson E, Paycha F, Leutenegger M, Attali JR: Predictive value of cardiac autonomic neuropathy in diabetic patients with or without silent myocardial ischemia. Diabetes Care 24 : 339 ？343, 2001 11213889
132 Mogensen CE: Nephropathy. In Handbook of Exercise in Diabetes. 2nd ed. Ruderman N, Devlin JT, Kriska A, Eds. Alexandria, VA, American Diabetes Association, 2002 , p. 433 ？449
133 Anderson RJ, Grigsby AB, Freedland KE, de Groot M, McGill JB, Clouse RE, Lustman PJ: Anxiety and poor glycemic control: a meta-analytic review of the literature. Int J Psychiatry Med 32 : 235 ？247, 2002 12489699
134 Jacobson AM: Depression and diabetes. Diabetes Care 16 : 1621 ？1623, 1993 8299460
135 Rubin RR, Peyrot M: Psychosocial problems and interventions in diabetes: a review of the literature. Diabetes Care 15 : 1640 ？1657, 1992 1468297
136 Surwit RS, Schneider MS, Feinglos MN: Stress and diabetes mellitus. Diabetes Care 15 : 1413 ？1422, 1992 1425110
137 Young-Hyman D: Psycosocial factors affecting adherence, quality of life, and well-being: Helping patients cope. In Medical Management of Type 1 Diabetes. 4th ed. Bode B, Ed. Alexandria, VA, American Diabetes Association, 2004 , p. 162 ？182
138 Delahanty LM, Grant RW, Wittenberg E, Bosch JL, Wexler DJ, Cagliero E, Meigs JB: Association of diabetes-related emotional distress with diabetes treatment in primary care patients with type 2 diabetes. Diabet Med 24 : 48 ？54, 2007 17227324
139 Anderson BJ, Auslander WF, Jung KC, Miller JP, Santiago JV: Assessing family sharing of diabetes responsibilities. J Pediatr Psychol 15 : 477 ？492, 1990 2258796
140 McCulloch DK, Glasgow RE, Hampson SE, Wagner E: A systematic approach to diabetes management in the post-DCCT era. Diabetes Care 17 : 765 ？769, 1994 7924791
141 Rubin RR, Peyrot M: Psychological issues and treatments for people with diabetes. J ClinPsychol 57 : 457 ？478, 2001
142 Peyrot M, Rubin RR: Behavioral and psychosocial interventions in diabetes: a conceptual review. Diabetes Care 30 : 2433 ？2440, 2007 17666457
143 Lustman PJ, Griffith LS, Clouse RE, Cryer PE: Psychiatric illness in diabetes mellitus: relationship to symptoms and glucose control. J Nerv Ment Dis 174 : 736 ？742, 1986 3783141
144 Marcus MD, Wing RR: Eating disorders and diabetes. In Neuropsychological and Behavioral Aspects of Diabetes. Holmes CS, Ed. New York, Springer-Verlag, 1990 , p. 102 ？121
145 American Diabetes Association: Hyperglycemic crises in diabetes. Diabetes Care 27 (Suppl. 1): S94 ？S102, 2004 14693938
146 Cryer PE: Hypoglycaemia: the limiting factor in the glycaemic management of type I and type II diabetes. Diabetologia 45 : 937 ？948, 2002 12136392
147 Gannon MC, Nuttall FQ: Protein and diabetes. In American Diabetes Association Guide to Medical Nutrition Therapy for Diabetes. Franz MJ, Bantle JP, Eds. Alexandria, VA, American Diabetes Association, 1999 , p. 107 ？125
148 Cryer PE: Diverse causes of hypoglycemia-associated autonomic failure in diabetes. N Engl J Med 350 : 2272 ？2279, 2004 15163777
149 Cryer PE, Davis SN, Shamoon H: Hypoglycemia in diabetes. Diabetes Care 26 : 1902 ？1912, 2003 12766131
150 Smith SA, Poland GA: Use of influenza and pneumococcal vaccines in people with diabetes. Diabetes Care 23 : 95 ？108, 2000 10857977
151 Colquhoun AJ, Nicholson KG, Botha JL, Raymond NT: Effectiveness of influenza vaccine in reducing hospital admissions in people with diabetes. Epidemiol Infect 119 : 335 ？341, 1997 9440437
152 Bridges CB, Fukuda K, Uyeki TM, Cox NJ, Singleton JA: Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 51 : 1 ？31, 2002
153 American Diabetes Association: Influenza and pneumococcal immunization in diabetes (Position Statement). Diabetes Care 27 (Suppl. 1): S111 ？S113, 2004 14693944
154 Gaede P, Lund-Andersen H, Parving HH, Pedersen O: Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 358 : 580 ？591, 2008 18256393
155 Arauz-Pacheco C, Parrott MA, Raskin P: The treatment of hypertension in adult patients with diabetes. Diabetes Care 25 : 134 ？147, 2002 11772914
156 Haffner SM: Management of dyslipidemia in adults with diabetes. Diabetes Care 21 : 160 ？178, 1998 9538988
157 Colwell JA: Aspirin therapy in diabetes. Diabetes Care 20 : 1767 ？1771, 1997 9353620
158 Haire-Joshu D, Glasgow RE, Tibbs TL: Smoking and diabetes. Diabetes Care 22 : 1887 ？1898, 1999 10546025
159 Buse JB, Ginsberg HN, Barkis GL, Clark NG, Costa F, Eckel R, Fonseca V, Gerstein HC, Grundy S, Nesto RW, Pignone MP, Plutzky J, Porte D, Redberg R, Stitzel KF, Stone NJ: Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Diabetes Care 30 : 162 ？172, 2007 17192355
160 Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289 : 2560 ？2572, 2003 12748199
161 Bobrie G, Chatellier G, Genes N, Clerson P, Vaur L, Vaisse B, Menard J, Mallion JM: Cardiovascular prognosis of “masked hypertension” detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA 291 : 1342 ？1349, 2004 15026401
162 Sega R, Facchetti R, Bombelli M, Cesana G, Corrao G, Grassi G, Mancia G: Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation 111 : 1777 ？1783, 2005 15809377
163 Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38: UK Prospective Diabetes Study Group. BMJ 317 : 703 ？713, 1998 9732337
164 Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S, Menard J, Rahn KH, Wedel H, Westerling S: Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial: HOT Study Group. Lancet 351 : 1755 ？1762, 1998 9635947
165 Adler AI, Stratton IM, Neil HA, Yudkin JS, Matthews DR, Cull CA, Wright AD, Turner RC, Holman RR: Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ 321 : 412 ？419, 2000 10938049
166 Lewington S, Clarke R, Qizilbash N, Peto R, Collins R: Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360 : 1903 ？1913, 2002 12493255
167 Stamler J, Vaccaro O, Neaton JD, Wentworth D: Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16 : 434 ？444, 1993 8432214
168 Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, Obarzanek E, Conlin PR, Miller ER III, Simons-Morton DG, Karanja N, Lin PH: Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet: DASH-Sodium Collaborative Research Group. N Engl J Med 344 : 3 ？10, 2001 11136953
169 Tatti P, Pahor M, Byington RP, Di Mauro P, Guarisco R, Strollo G, Strollo F: Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM. Diabetes Care 21 : 597 ？603, 1998 9571349
170 Estacio RO, Jeffers BW, Hiatt WR, Biggerstaff SL, Gifford N, Schrier RW: The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension. N Engl J Med 338 : 645 ？652, 1998 9486993
171 Schrier RW, Estacio RO, Mehler PS, Hiatt WR: Appropriate blood pressure control in hypertensive and normotensive type 2 diabetes mellitus: a summary of the ABCD trial. Nat Clin Pract Nephrol 3 : 428 ？438, 2007 17653121
172 Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 288 : 2981 ？2997, 2002 12479763
173 Psaty BM, Lumley T, Furberg CD, Schellenbaum G, Pahor M, Alderman MH, Weiss NS: Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. JAMA 289 : 2534 ？2544, 2003 12759325
174 Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy: Heart Outcomes Prevention Evaluation Study Investigators. Lancet 355 : 253 ？259, 2000 10675071
175 Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, Michelson EL, Olofsson B, Ostergren J, Yusuf S, Pocock S: Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet 362 : 759 ？766, 2003 13678868
176 Granger CB, McMurray JJ, Yusuf S, Held P, Michelson EL, Olofsson B, Ostergren J, Pfeffer MA, Swedberg K: Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM- Alternative trial. Lancet 362 : 772 ？776, 2003 13678870
177 McMurray JJ, Ostergren J, Swedberg K, Granger CB, Held P, Michelson EL, Olofsson B, Yusuf S, Pfeffer MA: Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial. Lancet 362 : 767 ？771, 2003 13678869
178 Lindholm LH, Ibsen H, Dahlof B, Devereux RB, Beevers G, de Faire U, Fyhrquist F, Julius S, Kjeldsen SE, Kristiansson K, Lederballe-Pedersen O, Nieminen MS, Omvik P, Oparil S, Wedel H, Aurup P, Edelman J, Snapinn S: Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 359 : 1004 ？1010, 2002 11937179
179 Berl T, Hunsicker LG, Lewis JB, Pfeffer MA, Porush JG, Rouleau JL, Drury PL, Esmatjes E, Hricik D, Parikh CR, Raz I, Vanhille P, Wiegmann TB, Wolfe BM, Locatelli F, Goldhaber SZ, Lewis EJ: Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy. Ann Intern Med 138 : 542 ？549, 2003 12667024
180 Laffel LM, McGill JB, Gans DJ: The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria: North American Microalbuminuria Study Group. Am J Med 99 : 497 ？504, 1995 7485207
181 Bakris GL, Williams M, Dworkin L, Elliott WJ, Epstein M, Toto R, Tuttle K, Douglas J, Hsueh W, Sowers J: Preserving renal function in adults with hypertension and diabetes: a consensus approach: National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. AmJ Kidney Dis 36 : 646 ？661, 2000 10977801
182 Psaty BM, Smith NL, Siscovick DS, Koepsell TD, Weiss NS, Heckbert SR, Lemaitre RN, Wagner EH, Furberg CD: Health outcomes associated with antihypertensive therapies used as first-line agents: a systematic review and meta-analysis. JAMA 277 : 739 ？745, 1997 9042847
183 Patel A, MacMahon S, Chalmers J, Neal B, Woodward M, Billot L, Harrap S, Poulter N, Marre M, Cooper M, Glasziou P, Grobbee DE, Hamet P, Heller S, Liu LS, Mancia G, Mogensen CE, Pan CY, Rodgers A, Williams B: Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet 370 : 829 ？840, 2007 17765963
184 Sibai BM: Treatment of hypertension in pregnant women. N Engl J Med 335 : 257 ？265, 1996 8657243
185 Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina T, Peto R, Collins R, Simes R: Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 366 : 1267 ？1278, 2005 16214597
186 Pyorala K, Pedersen TR, Kjekshus J, Faergeman O, Olsson AG, Thorgeirsson G: Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease: a subgroup analysis of the Scandinavian Simvastatin Survival Study (4S). Diabetes Care 20 : 614 ？620, 1997 9096989
187 Heart Protection Study Collaborative Group: MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 361 : 2005 ？2016, 2003 12814710
188 Goldberg RB, Mellies MJ, Sacks FM, Moye LA, Howard BV, Howard WJ, Davis BR, Cole TG, Pfeffer MA, Braunwald E: Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial: the Care Investigators. Circulation 98 : 2513 ？2519, 1998 9843456
189 Shepherd J, Barter P, Carmena R, Deedwania P, Fruchart JC, Haffner S, Hsia J, Breazna A, LaRosa J, Grundy S, Waters D: Effect of lowering LDL cholesterol substantially below currently recommended levels in patients with coronary heart disease and diabetes: the Treating to New Targets (TNT) study. Diabetes Care 29 : 1220 ？1226, 2006 16731999
190 Sever PS, Poulter NR, Dahlof B, Wedel H, Collins R, Beevers G, Caulfield M, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O'Brien E, Ostergren J: Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial？Lipid-Lowering Arm (ASCOT-LLA). Diabetes Care 28 : 1151 ？1157, 2005 15855581
191 Knopp RH, d'Emden M, Smilde JG, Pocock SJ: Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: the Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in Non-insulin-dependent diabetes mellitus (ASPEN). Diabetes Care 29 : 1478 ？1485, 2006 16801565
192 Singh IM, Shishehbor MH, Ansell BJ: High-density lipoprotein as a therapeutic target: a systematic review. JAMA 298 : 786 ？798, 2007 17699012
193 Singh IM, Shishehbor MH, Ansell BJ: High-density lipoprotein as a therapeutic target: a systematic review. JAMA 298 : 786 ？798, 2007 17699012
194 Canner PL, Berge KG, Wenger NK, Stamler J, Friedman L, Prineas RJ, Friedewald W: Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin. J Am Coll Cardiol 8 : 1245 ？1255, 1986 3782631
195 Rubins HB, Robins SJ, Collins D, Fye CL, Anderson JW, Elam MB, Faas FH, Linares E, Schaefer EJ, Schectman G, Wilt TJ, Wittes J: Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol: Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. N Engl J Med 341 : 410 ？418, 1999 10438259
196 Frick MH, Elo O, Haapa K, Heinonen OP, Heinsalmi P, Helo P, Huttunen JK, Kaitaniemi P, Koskinen P, Manninen V: Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia: safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med 317 : 1237 ？1245, 1987 3313041
197 Keech A, Simes RJ, Barter P, Best J, Scott R, Taskinen MR, Forder P, Pillai A, Davis T, Glasziou P, Drury P, Kesaniemi YA, Sullivan D, Hunt D, Colman P, d'Emden M, Whiting M, Ehnholm C, Laakso M: Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet 366 : 1849 ？1861, 2005 16310551
198 Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285 : 2486 ？2497, 2001 11368702
199 Hayward RA, Hofer TP, Vijan S: Narrative review: lack of evidence for recommended low-density lipoprotein treatment targets: a solvable problem. Ann Intern Med 145 : 520 ？530, 2006 17015870
200 Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R, Joyal SV, Hill KA, Pfeffer MA, Skene AM: Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 350 : 1495 ？1504, 2004 15007110
201 de Lemos JA, Blazing MA, Wiviott SD, Lewis EF, Fox KA, White HD, Rouleau JL, Pedersen TR, Gardner LH, Mukherjee R, Ramsey KE, Palmisano J, Bilheimer DW, Pfeffer MA, Califf RM, Braunwald E: Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial. JAMA 292 : 1307 ？1316, 2004 15337732
202 Nissen SE, Tuzcu EM, Schoenhagen P, Brown BG, Ganz P, Vogel RA, Crowe T, Howard G, Cooper CJ, Brodie B, Grines CL, DeMaria AN: Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA 291 : 1071 ？1080, 2004 14996776
203 Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ: Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 110 : 227 ？239, 2004 15249516
204 Chasman DI, Posada D, Subrahmanyan L, Cook NR, Stanton VP Jr, Ridker PM: Pharmacogenetic study of statin therapy and cholesterol reduction. JAMA 291 : 2821 ？2827, 2004 15199031
205 Elam MB, Hunninghake DB, Davis KB, Garg R, Johnson C, Egan D, Kostis JB, Sheps DS, Brinton EA: Effect of niacin on lipid and lipoprotein levels and glycemic control in patients with diabetes and peripheral arterial disease: the ADMIT study: a randomized trial: Arterial Disease Multiple Intervention Trial. JAMA 284 : 1263 ？1270, 2000 10979113
206 Grundy SM, Vega GL, McGovern ME, Tulloch BR, Kendall DM, Fitz-Patrick D, Ganda OP, Rosenson RS, Buse JB, Robertson DD, Sheehan JP: Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the assessment of diabetes control and evaluation of the efficacy of niaspan trial. Arch Intern Med 162 : 1568 ？1576, 2002 12123399
207 Jones PH, and Davidson MH Reporting rate of rhabdomyolysis with fenofibrate + statin versus gemfibrozil + any statin. Am J Cardiol 95 : 120 ？122, 2005 15619408
208 Brunzell JD, Davidson M, Furberg CD, Goldberg RB, Howard BV, Stein JH, Witztum JL: Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation. Diabetes Care 31 : 811 ？822, 2008 18375431
209 Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Livingstone SJ, Thomason MJ, Mackness MI, Charlton-Menys V, Fuller JH: Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet 364 : 685 ？696, 2004 15325833
210 American Diabetes Association: Aspirin therapy in diabetes (Position Statement). Diabetes Care 27 (Suppl. 1): S72 ？S73, 2004 14693931
211 Hayden M, Pignone M, Phillips C, Mulrow C: Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 136 : 161 ？172, 2002 11790072
212 US Preventive Services Task Force: Aspirin for the primary prevention of cardiovascular events: recommendation and rationale. Ann Intern Med 136 : 157 ？160, 2002 11790071
213 Antithrombotic Trialists Collaboration: Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324 : 71 ？86, 2002 11786451
214 Smith SC Jr, Allen J, Blair SN, Bonow RO, Brass LM, Fonarow GC, Grundy SM, Hiratzka L, Jones D, Krumholz HM, Mosca L, Pasternak RC, Pearson T, Pfeffer MA, Taubert KA: AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation 113 : 2363 ？2372, 2006 16702489
215 Campbell CL, Smyth S, Montalescot G, Steinhubl SR: Aspirin dose for the prevention of cardiovascular disease: a systematic review. JAMA 297 : 2018 ？2024, 2007 17488967
216 Sacco M, Pellegrini F, Roncaglioni MC, Avanzini F, Tognoni G, Nicolucci A: Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial. Diabetes Care 26 : 3264 ？3272, 2003 14633812
217 Bhatt DL, Marso SP, Hirsch AT, Ringleb PA, Hacke W, Topol EJ: Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus. Am J Cardiol 90 : 625 ？628, 2002 12231089
218 American Diabetes Asociation: Smoking and diabetes (Position Statement). Diabetes Care 27 (Suppl. 1): S74 ？S75, 2004 14693932
219 US Preventive Services Task Force: Counseling to prevent tobacco use and tobacco-related diseases: recommendation statement. Rockville, MD, Agency for Healthcare Research and Quality, 2003
220 Ranney L, Melvin C, Lux L, McClain E, Lohr KN: Systematic review: smoking cessation intervention strategies for adults and adults in special populations. Ann Intern Med 145 : 845 ？856, 2006 16954352
221 Scognamiglio R, Negut C, Ramondo A, Tiengo A, Avogaro A: Detection of coronary artery disease in asymptomatic patients with type 2 diabetes mellitus. J Am Coll Cardiol 47 : 65 ？71, 2006 16386666
222 Boden WE, O'Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, Knudtson M, Dada M, Casperson P, Harris CL, Chaitman BR, Shaw L, Gosselin G, Nawaz S, Title LM, Gau G, Blaustein AS, Booth DC, Bates ER, Spertus JA, Berman DS, Mancini GB, Weintraub WS: Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 356 : 1503 ？1516, 2007 17387127
223 Wackers FJ, Chyun DA, Young LH, Heller GV, Iskandrian AE, Davey JA, Barrett EJ, Taillefer R, Wittlin SD, Filipchuk N, Ratner RE, Inzucchi SE: Resolution of asymptomatic myocardial ischemia in patients with type 2 diabetes in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) study. Diabetes Care 30 : 2892 ？2898, 2007 17682123
224 Braunwald E, Domanski MJ, Fowler SE, Geller NL, Gersh BJ, Hsia J, Pfeffer MA, Rice MM, Rosenberg YD, Rouleau JL: Angiotensin-converting-enzyme inhibition in stable coronary artery disease. N Engl J Med 351 : 2058 ？2068, 2004 15531767
225 Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial. Lancet 372 : 1174 ？1183, 2008 18757085
226 Garg JP, Bakris GL: Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease. Vasc Med 7 : 35 ？43, 2002 12083733
227 Klausen K, Borch-Johnsen K, Feldt-Rasmussen B, Jensen G, Clausen P, Scharling H, Appleyard M, Jensen JS: Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation 110 : 32 ？35, 2004 15210602
228 Gall MA, Hougaard P, Borch-Johnsen K, Parving HH: Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study. BMJ 314 : 783 ？788, 1997 9080995
229 Ravid M, Lang R, Rachmani R, Lishner M: Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus: a 7-year follow-up study. Arch Intern Med 156 : 286 ？289, 1996 8572838
230 Reichard P, Nilsson BY, Rosenqvist U: The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 329 : 304 ？309, 1993 8147960
231 Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial: the Diabetes Control and Complications (DCCT) Research Group. Kidney Int 47 : 1703 ？1720, 1995 7643540
232 Lewis EJ, Hunsicker LG, Bain RP, Rohde RD: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy: the Collaborative Study Group. N Engl J Med 329 : 1456 ？1462, 1993 8413456
233 Remuzzi G, Macia M, Ruggenenti P: Prevention and treatment of diabetic renal disease in type 2 diabetes: the BENEDICT study. J Am Soc Nephrol 17 : S90 ？S97, 2006 16565256
234 Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, Ritz E, Atkins RC, Rohde R, Raz I: Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 345 : 851 ？860, 2001 11565517
235 Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, Remuzzi G, Snapinn SM, Zhang Z, Shahinfar S: Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345 : 861 ？869, 2001 11565518
236 Parving HH, Lehnert H, Brochner-Mortensen J, Gomis R, Andersen S, Arner P: The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 345 : 870 ？878, 2001 11565519
237 Pepine CJ, Handberg EM, Cooper-DeHoff RM, Marks RG, Kowey P, Messerli FH, Mancia G, Cangiano JL, Garcia-Barreto D, Keltai M, Erdine S, Bristol HA, Kolb HR, Bakris GL, Cohen JD, Parmley WW: A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease: the International Verapamil-Trandolapril study (INVEST): a randomized controlled trial. JAMA 290 : 2805 ？2816, 2003 14657064
238 Bakris GL, Siomos M, Richardson D, Janssen I, Bolton WK, Hebert L, Agarwal R, Catanzaro D: ACE inhibition or angiotensin receptor blockade: impact on potassium in renal failure: VAL-K Study Group. Kidney Int 58 : 2084 ？2092, 2000 11044229
239 Mogensen CE, Neldam S, Tikkanen I, Oren S, Viskoper R, Watts RW, Cooper ME: Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study. BMJ 321 : 1440 ？1444, 2000 11110735
240 Schjoedt KJ, Jacobsen P, Rossing K, Boomsma F, Parving HH: Dual blockade of the renin-angiotensin-aldosterone system in diabetic nephropathy: the role of aldosterone. Horm Metab Res 37 (Suppl. 1): 4 ？8, 2005
241 Schjoedt KJ, Rossing K, Juhl TR, Boomsma F, Rossing P, Tarnow L, Parving HH: Beneficial impact of spironolactone in diabetic nephropathy. Kidney Int 68 : 2829 ？2836, 2005 16316360
242 Parving HH, Persson F, Lewis JB, Lewis EJ, Hollenberg NK: Aliskiren combined with losartan in type 2 diabetes and nephropathy. N Engl J Med 358 : 2433 ？2446, 2008 18525041
243 Pijls LT, de Vries H, Donker AJ, van Eijk JT: The effect of protein restriction on albuminuria in patients with type 2 diabetes mellitus: a randomized trial. Nephrol Dial Transplant 14 : 1445 ？1453, 1999 10383006
244 Pedrini MT, Levey AS, Lau J, Chalmers TC, Wang PH: The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases: a meta-analysis. Ann Intern Med 124 : 627 ？632, 1996 8607590
245 Hansen HP, Tauber-Lassen E, Jensen BR, Parving HH: Effect of dietary protein restriction on prognosis in patients with diabetic nephropathy. Kidney Int 62 : 220 ？228, 2002 12081581
246 Kasiske BL, Lakatua JD, Ma JZ, Louis TA: A meta-analysis of the effects of dietary protein restriction on the rate of decline in renal function. Am J Kidney Dis 31 : 954 ？961, 1998 9631839
247 Eknoyan G, Hostetter T, Bakris GL, Hebert L, Levey AS, Parving HH, Steffes MW, Toto R: Proteinuria and other markers of chronic kidney disease: a position statement of the national kidney foundation (NKF) and the national institute of diabetes and digestive and kidney diseases (NIDDK). Am J Kidney Dis 42 : 617 ？622, 2003 14520612
248 Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G: National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 139 : 137 ？147, 2003 12859163
249 Kramer H, Molitch ME: Screening for kidney disease in adults with diabetes. Diabetes Care 28 : 1813 ？1816, 2005 15983346
250 Kramer HJ, Nguyen QD, Curhan G, Hsu CY: Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus. JAMA 289 : 3273 ？3277, 2003 12824208
251 Tsalamandris C, Allen TJ, Gilbert RE, Sinha A, Panagiotopoulos S, Cooper ME, Jerums G: Progressive decline in renal function in diabetic patients with and without albuminuria. Diabetes 43 : 649 ？655, 1994 8168641
252 Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation: Modification of Diet in Renal Disease Study Group. Ann Intern Med 130 : 461 ？470, 1999 10075613
253 Levinsky NG: Specialist evaluation in chronic kidney disease: too little, too late. Ann Intern Med 137 : 542 ？543, 2002 12230357
254 American Diabetes Association: Nephropathy in diabetes (Position Statement). Diabetes Care 27 (Suppl. 1): S79 ？S83, 2004 14693934
255 Klein R: Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care 18 : 258 ？268, 1995 7729308
256 Estacio RO, McFarling E, Biggerstaff S, Jeffers BW, Johnson D, Schrier RW: Overt albuminuria predicts diabetic retinopathy in Hispanics with NIDDM. Am J Kidney Dis 31 : 947 ？953, 1998 9631838
257 Leske MC, Wu SY, Hennis A, Hyman L, Nemesure B, Yang L, Schachat AP: Hyperglycemia, blood pressure, and the 9-year incidence of diabetic retinopathy: the Barbados Eye Studies. Ophthalmology 112 : 799 ？805, 2005 15878059
258 Fong DS, Aiello LP, Ferris FL III, Klein R: Diabetic retinopathy. Diabetes Care 27 : 2540 ？2553, 2004 15451934
259 DCCT: Effect of pregnancy on microvascular complications in the diabetes control and complications trial: The Diabetes Control and Complications Trial Research Group. Diabetes Care 23 : 1084 ？1091, 2000 10937502
260 The Diabetic Retinopathy Study (DRS) Research Group: Preliminary report on the effects of photocoagulation therapy: DRS Report #1. Am J Ophthalmol 81 : 383 ？396, 1976 944535
261 Photocoagulation for diabetic macular edema: Early Treatment Diabetic Retinopathy Study report number 1: Early Treatment Diabetic Retinopathy Study Research Group. Arch Ophthalmol 103 : 1796 ？1806, 1985 2866759
262 Klein R, Klein BE, Moss SE, Davis MD, DeMets DL: The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 102 : 520 ？526, 1984 6367724
263 Harris MI, Klein R, Welborn TA, Knuiman MW: Onset of NIDDM occurs at least 4？7 yr before clinical diagnosis. Diabetes Care 15 : 815 ？819, 1992 1516497
264 Vijan S, Hofer TP, Hayward RA: Cost-utility analysis of screening intervals for diabetic retinopathy in patients with type 2 diabetes mellitus. JAMA 283 : 889 ？896, 2000 10685713
265 Klein R: Screening interval for retinopathy in type 2 diabetes. Lancet 361 : 190 ？191, 2003 12547536
266 Younis N, Broadbent DM, Vora JP, Harding SP: Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study. Lancet 361 : 195 ？200, 2003 12547541
267 Ahmed J, Ward TP, Bursell SE, Aiello LM, Cavallerano JD, Vigersky RA: The sensitivity and specificity of nonmydriatic digital stereoscopic retinal imaging in detecting diabetic retinopathy. Diabetes Care 29 : 2205 ？2209, 2006 17003294
268 American Diabetes Association: Retinopathy in diabetes. Diabetes Care 27 (Suppl. 1): S84 ？S87, 2004 14693935
269 Ciulla TA, Amador AG, Zinman B: Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies. Diabetes Care 26 : 2653 ？2664, 2003 12941734
270 Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, Malik RA, Maser RE, Sosenko JM, Ziegler D: Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 28 : 956 ？962, 2005 15793206
271 Vinik AI, Maser RE, Mitchell BD, Freeman R: Diabetic autonomic neuropathy. Diabetes Care 26 : 1553 ？1579, 2003 12716821
272 Boulton AJ, Armstrong DG, Albert SF, Frykberg RG, Hellman R, Kirkman MS, Lavery LA, Lemaster JW, Mills JL Sr, Mueller MJ, Sheehan P, Wukich DK: Comprehensive foot examination and risk assessment: a report of the task force of the foot care interest group of the American Diabetes Association, with endorsement by the American Association of Clinical Endocrinologists. Diabetes Care 31 : 1679 ？1685, 2008 18663232
273 American Diabetes Association: Peripheral arterial disease in people with diabetes (Consensus Statement). Diabetes Care 26 : 3333 ？3341, 2003 14633825
274 American Diabetes Association: Consensus Development Conference on Diabetic Foot Wound Care: 7？8 April 1999, Boston, Massachusetts. Diabetes Care 22 : 1354 ？1360, 1999 10480782
275 Silverstein J, Klingensmith G, Copeland KC, Plotnick L, Kaufman F, Laffel L, Deeb LC, Grey M, Anderson BJ, Holzmeister LA, Clark NG: Care of children and adolescents with type 1 diabetes mellitus: a statement of the American Diabetes Association. Diabetes Care 28 : 186 ？212, 2005 15616254
276 Northam EA, Anderson PJ, Werther GA, Warne GL, Adler RG, Andrewes D: Neuropsychological complications of IDDM in children 2 years after disease onset. Diabetes Care 21 : 379 ？384, 1998 9540019
277 Rovet J, Alvarez M: Attentional functioning in children and adolescents with IDDM. Diabetes Care 20 : 803 ？810, 1997 9135946
278 Bjorgaas M, Gimse R, Vik T, Sand T: Cognitive function in type 1 diabetic children with and without episodes of severe hypoglycaemia. Acta Paediatr 86 : 148 ？153, 1997 9055883
279 Doyle EA, Weinzimer SA, Steffen AT, Ahern JA, Vincent M, Tamborlane WV: A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine. Diabetes Care 27 : 1554 ？1558, 2004 15220227
280 Nimri R, Weintrob N, Benzaquen H, Ofan R, Fayman G, Phillip M: Insulin pump therapy in youth with type 1 diabetes: a retrospective paired study. Pediatrics 117 : 2126 ？2131, 2006 16740856
281 Krantz JS, Mack WJ, Hodis HN, Liu CR, Liu CH, Kaufman FR: Early onset of subclinical atherosclerosis in young persons with type 1 diabetes. J Pediatr 145 : 452 ？457, 2004 15480366
282 Jarvisalo MJ, Putto-Laurila A, Jartti L, Lehtimaki T, Solakivi T, Ronnemaa T, Raitakari OT: Carotid artery intima-media thickness in children with type 1 diabetes. Diabetes 51 : 493 ？498, 2002 11812760
283 Haller MJ, Samyn M, Nichols WW, Brusko T, Wasserfall C, Schwartz RF, Atkinson M, Shuster JJ, Pierce GL, Silverstein JH: Radial artery tonometry demonstrates arterial stiffness in children with type 1 diabetes. Diabetes Care 27 : 2911 ？2917, 2004 15562206
284 Orchard TJ, Forrest KY, Kuller LH, Becker DJ: Lipid and blood pressure treatment goals for type 1 diabetes: 10-year incidence data from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care 24 : 1053 ？1059, 2001 11375370
285 Kavey RE, Allada V, Daniels SR, Hayman LL, McCrindle BW, Newburger JW, Parekh RS, Steinberger J: Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation 114 : 2710 ？2738, 2006 17130340
286 McCrindle BW, Urbina EM, Dennison BA, Jacobson MS, Steinberger J, Rocchini AP, Hayman LL, Daniels SR: Drug therapy of high-risk lipid abnormalities in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, with the Council on Cardiovascular Nursing. Circulation 115 : 1948 ？1967, 2007 17377073
287 Salo P, Viikari J, Hamalainen M, Lapinleimu H, Routi T, Ronnemaa T, Seppanen R, Jokinen E, Valimaki I, Simell O: Serum cholesterol ester fatty acids in 7- and 13-month-old children in a prospective randomized trial of a low-saturated fat, low-cholesterol diet: the STRIP baby project: Special Turku coronary Risk factor Intervention Project for children. Acta Paediatr 88 : 505 ？512, 1999 10426172
288 Efficacy and safety of lowering dietary intake of fat and cholesterol in children with elevated low-density lipoprotein cholesterol: the Dietary Intervention Study in Children (DISC): the Writing Group for the DISC Collaborative Research Group. JAMA 273 : 1429 ？1435, 1995 7723156
289 McCrindle BW, Ose L, Marais AD: Efficacy and safety of atorvastatin in children and adolescents with familial hypercholesterolemia or severe hyperlipidemia: a multicenter, randomized, placebo-controlled trial. J Pediatr 143 : 74 ？80, 2003 12915827
290 de Jongh S, Lilien MR, op't RJ, Stroes ES, Bakker HD, Kastelein JJ: Early statin therapy restores endothelial function in children with familial hypercholesterolemia. J Am Coll Cardiol 40 : 2117 ？2121, 2002 12505222
291 Wiegman A, Hutten BA, de Groot E, Rodenburg J, Bakker HD, Buller HR, Sijbrands EJ, Kastelein JJ: Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial. JAMA 292 : 331 ？337, 2004 15265847
292 Holmes GK: Screening for coeliac disease in type 1 diabetes. Arch Dis Child 87 : 495 ？498, 2002 12456547
293 Rewers M, Liu E, Simmons J, Redondo MJ, Hoffenberg EJ: Celiac disease associated with type 1 diabetes mellitus. Endocrinol Metab Clin North Am 33 : 197 ？214, 2004 15053903
294 Roldan MB, Alonso M, Barrio R: Thyroid autoimmunity in children and adolescents with type 1 diabetes mellitus. Diabetes Nutr Metab 12 : 27 ？31, 1999 10517303
295 Kordonouri O, Deiss D, Danne T, Dorow A, Bassir C, Gruters-Kieslich A: Predictivity of thyroid autoantibodies for the development of thyroid disorders in children and adolescents with type 1 diabetes. Diabet Med 19 : 518 ？521, 2002 12060066
296 Mohn A, Di Michele S, Di Luzio R, Tumini S, Chiarelli F: The effect of subclinical hypothyroidism on metabolic control in children and adolescents with type 1 diabetes mellitus. Diabet Med 19 : 70 ？73, 2002 11869306
297 Chase HP, Garg SK, Cockerham RS, Wilcox WD, Walravens PA: Thyroid hormone replacement and growth of children with subclinical hypothyroidism and diabetes. Diabet Med 7 : 299 ？303, 1990 2140081
298 Eppens MC, Craig ME, Cusumano J, Hing S, Chan AK, Howard NJ, Silink M, Donaghue KC: Prevalence of diabetes complications in adolescents with type 2 compared with type 1 diabetes. Diabetes Care 29 : 1300 ？1306, 2006 16732012
299 Kitzmiller JL, Gavin LA, Gin GD, Jovanovic-Peterson L, Main EK, Zigrang WD: Preconception care of diabetes: glycemic control prevents congenital anomalies. JAMA 265 : 731 ？736, 1991 1990188
300 Goldman JA, Dicker D, Feldberg D, Yeshaya A, Samuel N, Karp M: Pregnancy outcome in patients with insulin-dependent diabetes mellitus with preconceptional diabetic control: a comparative study. AmJ Obstet Gynecol 155 : 293 ？297, 1986 3740144
301 Rosenn B, Miodovnik M, Combs CA, Khoury J, Siddiqi TA: Pre-conception management of insulin-dependent diabetes: improvement of pregnancy outcome. Obstet Gynecol 77 : 846 ？849, 1991 2030855
302 Tchobroutsky C, Vray MM, Altman JJ: Risk/benefit ratio of changing late obstetrical strategies in the management of insulin-dependent diabetic pregnancies: a comparison between 1971？1977 and 1978？1985 periods in 389 pregnancies. Diabete Metab 17 : 287 ？294, 1991 1864436
303 Willhoite MB, Bennert HW Jr, Palomaki GE, Zaremba MM, Herman WH, Williams JR, Spear NH: The impact of preconception counseling on pregnancy outcomes: the experience of the Maine Diabetes in Pregnancy Program. Diabetes Care 16 : 450 ？455, 1993 8432216
304 Cooper WO, Hernandez-Diaz S, Arbogast PG, Dudley JA, Dyer S, Gideon PS, Hall K, Ray WA: Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med 354 : 2443 ？2451, 2006 16760444
305 Kitzmiller JL, Buchanan TA, Kjos S, Combs CA, Ratner RE: Pre-conception care of diabetes, congenital malformations, and spontaneous abortions. Diabetes Care 19 : 514 ？541, 1996 8732721
306 American Diabetes Association: Preconception care of women with diabetes (Position Statement). Diabetes Care 27 (Suppl. 1): S76 ？S78, 2004 14693933
307 Brown AF, Mangione CM, Saliba D, Sarkisian CA: Guidelines for improving the care of the older person with diabetes mellitus. J Am Geriatr Soc 51 : S265 ？S280, 2003 12694461
308 Curb JD, Pressel SL, Cutler JA, Savage PJ, Applegate WB, Black H, Camel G, Davis BR, Frost PH, Gonzalez N, Guthrie G, Oberman A, Rutan GH, Stamler J: Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension: Systolic Hypertension in the Elderly Program Cooperative Research Group. JAMA 276 : 1886 ？1892, 1996 8968014
309 Beckett NS, Peters R, Fletcher AE, Staessen JA, Liu L, Dumitrascu D, Stoyanovsky V, Antikainen RL, Nikitin Y, Anderson C, Belhani A, Forette F, Rajkumar C, Thijs L, Banya W, Bulpitt CJ: Treatment of hypertension in patients 80 years of age or older. N Engl J Med 358 : 1887 ？1898, 2008 18378519
310 Clement S, Braithwaite SS, Magee MF, Ahmann A, Smith EP, Schafer RG, Hirsh IB: Management of diabetes and hyperglycemia in hospitals. Diabetes Care 27 : 553 ？591, 2004 14747243
311 American Association of Clinical Endocrinologists: Inpatient diabetes and metabolic control: conference proceedings. Endocr Pract 10 (Suppl. 2): 1 ？108, 2004 15152625
312 Garber AJ, Moghissi ES, Bransome ED Jr, Clark NG, Clement S, Cobin RH, Furnary AP, Hirsch IB, Levy P, Roberts R, van den BG, Zamudio V: American College of Endocrinology position statement on inpatient diabetes and metabolic control. EndocrPract 10 (Suppl. 2): 4 ？9, 2004
313 ACE/ADA Task Force on Inpatient Diabetes: American College of Endocrinology and American Diabetes Association Consensus statement on inpatient diabetes and glycemic control: a call to action. Diabetes Care 29 : 1955 ？1962, 2006 16873812
314 Centers for Disease Control and Prevention: Hospitalizations for Diabetes as Any-Listed Diagnosis. National Diabetes Surveillance System. Atlanta, Georgia, Centers for Disease Control and Prevention, 2003
315 Pomposelli JJ, Baxter JK III, Babineau TJ, Pomfret EA, Driscoll DF, Forse RA, Bistrian BR: Early postoperative glucose control predicts nosocomial infection rate in diabetic patients. J Parenter Enteral Nutr 22 : 77 ？81, 1998
316 Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE: Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 87 : 978 ？982, 2002 11889147
317 Capes SE, Hunt D, Malmberg K, Gerstein HC: Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 355 : 773 ？778, 2000 10711923
318 Bolk J, van der PT, Cornel JH, Arnold AE, Sepers J, Umans VA: Impaired glucose metabolism predicts mortality after a myocardial infarction. Int J Cardiol 79 : 207 ？214, 2001 11461743
319 Malmberg K: Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus: DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. BMJ 314 : 1512 ？1515, 1997 9169397
320 Malmberg K, Ryden L, Efendic S, Herlitz J, Nicol P, Waldenstrom A, Wedel H, Welin L: Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol 26 : 57 ？65, 1995 7797776
321 Malmberg K, Ryden L, Wedel H, Birkeland K, Bootsma A, Dickstein K, Efendic S, Fisher M, Hamsten A, Herlitz J, Hildebrandt P, MacLeod K, Laakso M, Torp-Pedersen C, Waldenstrom A: Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J 26 : 650 ？661, 2005 15728645
322 Mehta SR, Yusuf S, Diaz R, Zhu J, Pais P, Xavier D, Paolasso E, Ahmed R, Xie C, Kazmi K, Tai J, Orlandini A, Pogue J, Liu L: Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. JAMA 293 : 437 ？446, 2005 15671428
323 Cheung NW, Wong VW, McLean M: The hyperglycemia: intensive insulin infusion in infarction (HI-5) study: a randomized controlled trial of insulin infusion therapy for myocardial infarction. Diabetes Care 29 : 765 ？770, 2006 16567812
324 Furnary AP, Gao G, Grunkemeier GL, Wu Y, Zerr KJ, Bookin SO, Floten HS, Starr A: Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 125 : 1007 ？1021, 2003 12771873
325 Furnary AP, Zerr KJ, Grunkemeier GL, Starr A: Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg 67 : 352 ？360, 1999 10197653
326 Golden SH, Peart-Vigilance C, Kao WH, Brancati FL: Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes. Diabetes Care 22 : 1408 ？1414, 1999 10480501
327 Zerr KJ, Furnary AP, Grunkemeier GL, Bookin S, Kanhere V, Starr A: Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg 63 : 356 ？361, 1997 9033300
328 van den BG, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R: Intensive insulin therapy in the critically ill patients. N Engl J Med 345 : 1359 ？1367, 2001 11794168
329 van den BG, Wouters PJ, Bouillon R, Weekers F, Verwaest C, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P: Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med 31 : 359 ？366, 2003 12576937
330 van den BG, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R: Intensive insulin therapy in the medical ICU. N Engl J Med 354 : 449 ？461, 2006 16452557
331 Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffler M, Reinhart K: Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 358 : 125 ？139, 2008 18184958
332 Pittas AG, Siegel RD, Lau J: Insulin therapy for critically ill hospitalized patients: a meta-analysis of randomized controlled trials. Arch Intern Med 164 : 2005 ？2011, 2004 15477435
333 Wiener RS, Wiener DC, Larson RJ: Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. JAMA 300 : 933 ？944, 2008 18728267
334 Krinsley J: Glycemic control in critically ill patients: Leuven and beyond. Chest 132 : 1 ？2, 2007 17625075
335 Miller CD, Phillips LS, Ziemer DC, Gallina DL, Cook CB, El Kebbi IM: Hypoglycemia in patients with type 2 diabetes mellitus. Arch Intern Med 161 : 1653 ？1659, 2001 11434798
336 Misbin RI, Green L, Stadel BV, Gueriguian JL, Gubbi A, Fleming GA: Lactic acidosis in patients with diabetes treated with metformin. N Engl J Med 338 : 265 ？266, 1998 9441244
337 Misbin RI: The phantom of lactic acidosis due to metformin in patients with diabetes. Diabetes Care 27 : 1791 ？1793, 2004 15220268
338 Salpeter SR, Greyber E, Pasternak GA, Salpeter EE: Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus: systematic review and meta-analysis. Arch Intern Med 163 : 2594 ？2602, 2003 14638559
339 Queale WS, Seidler AJ, Brancati FL: Glycemic control and sliding scale insulin use in medical inpatients with diabetes mellitus. Arch Intern Med 157 : 545 ？552, 1997 9066459
340 Gearhart JG, Duncan JL, III, Replogle WH, Forbes RC, Walley EJ: Efficacy of sliding-scale insulin therapy: a comparison with prospective regimens. Fam Pract Res J 14 : 313 ？322, 1994 7863803
341 Walts LF, Miller J, Davidson MB, Brown J: Perioperative management of diabetes mellitus. Anesthesiology 55 : 104 ？109, 1981 7020488
342 Umpierrez GE, Smiley D, Zisman A, Prieto LM, Palacio A, Ceron M, Puig A, Mejia R: Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care 30 : 2181 ？2186, 2007 17513708
343 Schmeltz LR, DeSantis AJ, Schmidt K, O'Shea-Mahler E, Rhee C, Brandt S, Peterson S, Molitch ME: Conversion of intravenous insulin infusions to subcutaneously administered insulin glargine in patients with hyperglycemia. Endocr Pract 12 : 641 ？650, 2006 17229660
344 Shilo S, Berezovsky S, Friedlander Y, Sonnenblick M: Hypoglycemia in hospitalized nondiabetic older patients. J Am Geriatr Soc 46 : 978 ？982, 1998 9706886
345 Fischer KF, Lees JA, Newman JH: Hypoglycemia in hospitalized patients: causes and outcomes. N Engl J Med 315 : 1245 ？1250, 1986 3534567
346 Markovitz LJ, Wiechmann RJ, Harris N, Hayden V, Cooper J, Johnson G, Harelstad R, Calkins L, Braithwaite SS: Description and evaluation of a glycemic management protocol for patients with diabetes undergoing heart surgery. EndocrPract 8 : 10 ？18, 2002
347 Levetan CS, Salas JR, Wilets IF, Zumoff B: Impact of endocrine and diabetes team consultation on hospital length of stay for patients with diabetes. Am J Med 99 : 22 ？28, 1995 7598138
348 Levetan CS, Passaro MD, Jablonski KA, Ratner RE: Effect of physician specialty on outcomes in diabetic ketoacidosis. Diabetes Care 22 : 1790 ？1795, 1999 10546009
349 Koproski J, Pretto Z, Poretsky L: Effects of an intervention by a diabetes team in hospitalized patients with diabetes. Diabetes Care 20 : 1553 ？1555, 1997 9314634
350 Furnary AP, Braithwaite SS: Effects of outcome on in-hospital transition from intravenous insulin infusion to subcutaneous therapy. Am J Cardiol 98 : 557 ？564, 2006 16893717
351 American Diabetes Association: Diabetes nutrition recommendations for health care institutions (Position Statement). Diabetes Care 27 (Suppl. 1): S55 ？S57, 2004 14693926
352 Boucher JL, Swift CS, Franz MJ, Kulkarni K, Schafer RG, Pritchett E, Clark NG: Inpatient management of diabetes and hyperglycemia: implications for nutrition practice and the food and nutrition professional. J Am Diet Assoc 107 : 105 ？111, 2007 17197277
353 American Diabetes Association: Diabetes care in the school and day care setting. Diabetes Care 29 (Suppl. 1): S49 ？S55, 2006 16373933
354 National Diabetes Education Program: Helping the student with diabetes succeed: a guide for school personnel (article online), 2006 . Available from http://www.ndep.nih.gov/resources/school.htm
355 American Diabetes Association: Diabetes care tasks at school: what key personnel need to know (article online), 2005 . Available from http://diabetes.org
356 American Diabetes Association: Diabetes care at diabetes camps. Diabetes Care 29 (Suppl. 1): S56 ？S58, 2006 16373934
357 American Diabetes Association: Diabetes management in correctional institutions. Diabetes Care 29 (Suppl. 1): S59 ？S66, 2006 16373935
358 American Diabetes Association Statement on Emergency and Disaster Preparedness: a report of the Disaster Response Task Force. Diabetes Care 30 : 2395 ？2398, 2007 17623820
359 Cefalu WT, Smith SR, Blonde L, Fonseca V: The Hurricane Katrina aftermath and its impact on diabetes care: observations from “ground zero”: lessons in disaster preparedness of people with diabetes. Diabetes Care 29 : 158 ？160, 2006 16373918
360 American Diabetes Association: Hypoglycemia and employment/licensure. Diabetes Care 29 (Suppl. 1): S67 , 2006 16373936
361 American Diabetes Association: Third-party reimbursement for diabetes care, self-management education, and supplies. Diabetes Care 29 (Suppl. 1): S68 ？S69, 2006 16373937
362 Saydah SH, Fradkin J, Cowie CC: Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA 291 : 335 ？342, 2004 14734596
363 Clark CM Jr, Snyder JW, Meek RL, Stutz LM, Parkin CG: A systematic approach to risk stratification and intervention within a managed care environment improves diabetes outcomes and patient satisfaction. Diabetes Care 24 : 1079 ？1086, 2001 11375374
364 Meigs JB, Cagliero E, Dubey A, Murphy-Sheehy P, Gildesgame C, Chueh H, Barry MJ, Singer DE, Nathan DM: A controlled trial of web-based diabetes disease management: the MGH diabetes primary care improvement project. Diabetes Care 26 : 750 ？757, 2003 12610033
365 O'Connor PJ, Desai J, Solberg LI, Reger LA, Crain AL, Asche SE, Pearson TL, Clark CK, Rush WA, Cherney LM, Sperl-Hillen JM, Bishop DB: Randomized trial of quality improvement intervention to improve diabetes care in primary care settings. Diabetes Care 28 : 1890 ？1897, 2005 16043728
366 Sperl-Hillen JM, O'Connor PJ: Factors driving diabetes care improvement in a large medical group: ten years of progress. Am J Manag Care 11 : S177 ？S185, 2005 16111440
367 Siminerio LM: Implementing diabetes self-management training programs: breaking through the barriers in primary care. Endocr Pract 12 (Suppl. 1): 124 ？130, 2006 16627396
368 Mahoney JJ: Reducing patient drug acquisition costs can lower diabetes health claims. Am J Manag Care 11 : S170 ？S176, 2005 16111439
369 Maney M, Tseng CL, Safford MM, Miller DR, Pogach LM: Impact of self-reported patient characteristics upon assessment of glycemic control in the Veterans Health Administration. Diabetes Care 30 : 245 ？251, 2007 17259489
370 Bergenstal RM: Treatment models from the International Diabetes Center: advancing from oral agents to insulin therapy in type 2 diabetes. Endocr Pract 12 (Suppl. 1): 98 ？104, 2006 16627391
371 O'Connor PJ: Electronic medical records and diabetes care improvement: are we waiting for Godot? Diabetes Care 26 : 942 ？943, 2003 12610062
372 Shojania KG, Ranji SR, McDonald KM, Grimshaw JM, Sundaram V, Rushakoff RJ, Owens DK: Effects of quality improvement strategies for type 2 diabetes on glycemic control: a meta-regression analysis. JAMA 296 : 427 ？440, 2006 16868301
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
저자가 APC(Article Processing Charge)를 지불한 논문에 한하여 자유로운 이용이 가능한, hybrid 저널에 출판된 논문
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.